Search Results 8501-8510 of 35392 for oral

1. Karl A. Nath, M.D. - Doctors and Medical Staff - Mayo Clinic

   Congress prize for best oral presentationFifth International Congress on Nutrition and Metabolism in Renal Disease, Strasbourg, France. 1988. First ...

2. Salivary gland tumors - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

3. Publications - Michael R. Henry, M.D. - Mayo Clinic

   Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia . J Womens Health (Larchmt) ...

4. Standardized prescribing guidelines reduce frequency and quantity of opioids prescribed - Mayo Clinic

   ... oral morphine equivalent (OME) after any ophthalmic surgery. Pain management education. The study team provided pain management education to all ophthalmic ...

5. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

   Treatment was 160 mg of oral zanubrutinib twice daily (n = 50) or 320 mg once daily (n = 23). Efficacy endpoints included overall response rate (ORR) and ...

6. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Able to swallow and retain oral medications and without gastrointestinal (GI) illnesses that would preclude absorption of cediranib or olaparib; Women of ...

7. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

   Cladribine, mitoxantrone, or oral cyclophosphamide at any time. Treatment with any investigational agent within 24 weeks or 5 drug-elimination half-lives of ...

8. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

   Requires intermittent or chronic systemic (intravenous or oral) treatment with an antiherpetic drug (eg, acyclovir), other than intermittent topical use ...

9. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   Able to swallow oral medication. Both female and male patients of reproductive potential must agree to avoid pregnancy or impregnating a partner ...

10. Publications - Angela M. Donaldson, M.D. - Mayo Clinic

    Sinonasal Outcomes Using Oral Corticosteroids in Patients with Chronic Rhinosinusitis with Nasal Polyps and Positive Sinonasal Cultures. Int Arch ...